Atlas Trials

Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19

Clinical trial NCT04645368 · COMPLETED

Trial details

NCT number
NCT04645368
Sponsor
NPO Petrovax
Status
COMPLETED
Study type
OBSERVATIONAL
Fibroses, Pulmonary
Start date
2020-07-01
Primary completion
2022-04-20
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.